OMIX

CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia

OMIX001035

1Summary
Title CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Description We transplanted CRISPR-edited CCR5-ablated hematopoietic stem and progenitor cells (HSPCs) into a patient with HIV-1 infection and acute lymphoblastic leukemia. The acute lymphoblastic leukemia was in complete remission with full donor chimerism, and donor cells carrying the ablated CCR5 persisted for more than 19 months without gene editing-related adverse events. The percentage of CD4+ cells with CCR5 ablation increased by a small degree during a period of antiretroviral-therapy interruption. Although we achieved successful transplantation and long-term engraftment of CRISPR-edited HSPCs, the percentage of CCR5 disruption in lymphocytes was only approximately 5%, which indicates the need for further research into this approach.
Organism Homo sapiens
Data Type Genotype
Data Accessibility Open-access
BioProject PRJCA008651
Release Date 2023-12-16
Submitter Hongkui Deng (hongkui_deng@pku.edu.cn)
Organization Peking University
Submission Date 2022-03-15
2Files & Download

The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX001035-06-01 sp15 gene mutation analysis.xls 1 Genotype 46.6 KB xls 0 Unavailable
OMIX001035-06-02 sp44 gene mutation analysis.xls 1 Genotype 55.4 KB xls 0 Unavailable

View All Released Data of OMIX